Xorte logo

News Markets Groups

USA | Europe | Asia | World| Stocks | Commodities



Add a new RSS channel

 
 


Keywords

2020-08-06 08:05:44| Mondaq.Com

A publicly traded global pharmaceutical company and several former executives settled SEC charges for making misleading disclosures to investors in financial reports and earning presentations.

Tags company united states united states

Category: News and Media

 

Latest from this category

25.12UN turns 80 in 2025 amid global crises, India says ready for greater role
25.12Stocks to buy on Friday: Jio Financial, APL Apollo, 3 more scrips offer up to 16% upside
25.12ETMarkets Smart Talk: How to Build a Rs 10 lakh portfolio for 2026 with equities, gold, silver and bonds, Sunny Agrawal of SBI Securities decodes
25.12Bangladesh: BNP acting chairman Tarique Rahman, Khaleda Zia's son, lands in Dhaka amid growing unrest
25.12India tops global IPO volumes in November; ranks second in issue value at $3.7 billion, ahead of US
25.12Why China, a one-party state, is backing elections in a neighbouring country
25.12Explained: Sebi eases norms for duplicate securities, increases limit, and simplifies documentation. 5 things to know
25.12Where should you invest Rs 12 crore in real estate in 2026? B.K. Malag explains
News and Media »

All news

25.12UN turns 80 in 2025 amid global crises, India says ready for greater role
25.12Stocks to buy on Friday: Jio Financial, APL Apollo, 3 more scrips offer up to 16% upside
25.12ETMarkets Smart Talk: How to Build a Rs 10 lakh portfolio for 2026 with equities, gold, silver and bonds, Sunny Agrawal of SBI Securities decodes
25.12Bangladesh: BNP acting chairman Tarique Rahman, Khaleda Zia's son, lands in Dhaka amid growing unrest
25.12Heres why visiting museums between Christmas and New Years makes me a better leader
25.12India tops global IPO volumes in November; ranks second in issue value at $3.7 billion, ahead of US
25.12Why China, a one-party state, is backing elections in a neighbouring country
25.12Explained: Sebi eases norms for duplicate securities, increases limit, and simplifies documentation. 5 things to know
More »
Privacy policy . Copyright . Contact form .